{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:38:39Z","timestamp":1773272319868,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejpn.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T10:23:23Z","timestamp":1559816603000},"page":"345-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The expanding spectrum of ATP1A3 related disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Cecilia","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad A.","family":"Mikati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2019.05.007_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2019.02.004","article-title":"Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3","author":"Sabouraud","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2019.05.007_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11940-017-0444-7","article-title":"Diagnosis and treatment of alternating hemiplegia of childhood","volume":"19","author":"Masoud","year":"2017","journal-title":"Curr Treat Options Neurol"},{"issue":"11","key":"10.1016\/j.ejpn.2019.05.007_bib3","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bbabio.2016.08.009","article-title":"Neurological disease mutations of alpha3 Na(+),K(+)-ATPase: structural and functional perspectives and rescue of compromised function","volume":"1857","author":"Holm","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.ejpn.2019.05.007_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1474-4422(14)70011-0","article-title":"Distinct neurological disorders with ATP1A3 mutations","volume":"13","author":"Heinzen","year":"2014","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2019.05.007_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1074\/jbc.RA118.004591","article-title":"Functional consequences of the CAPOS mutation E818K of Na+,K+-ATPase","volume":"294","author":"Roenn","year":"2019","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.ejpn.2019.05.007_bib6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/epi.14441","article-title":"Mechanisms of increased hippocampal excitability in the Mashl(+\/-) mouse model of Na(+)\/K(+) -ATPase dysfunction","volume":"59","author":"Hunanyan","year":"2018","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejpn.2019.05.007_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/epi.12878","article-title":"Knock-in mouse model of alternating hemiplegia of childhood: behavioral and electrophysiologic characterization","volume":"56","author":"Hunanyan","year":"2015","journal-title":"Epilepsia"},{"issue":"33","key":"10.1016\/j.ejpn.2019.05.007_bib8","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1073\/pnas.0904817106","article-title":"Mutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS","volume":"106","author":"Clapcote","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejpn.2019.05.007_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2018.03.009","article-title":"Direct evidence of impaired neuronal Na\/K-ATPase pump function in alternating hemiplegia of childhood","volume":"115","author":"Simmons","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.ejpn.2019.05.007_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006763","article-title":"Hypothermia-induced dystonia and abnormal cerebellar activity in a mouse model with a single disease-mutation in the sodium-potassium pump","volume":"13","author":"Isaksen","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ejpn.2019.05.007_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2018.07.028","article-title":"Novel E815K knock-in mouse model of alternating hemiplegia of childhood","volume":"119","author":"Helseth","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.ejpn.2019.05.007_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpn.2017.12.009","article-title":"ATP1A3-related disorders: an update","volume":"22","author":"Carecchio","year":"2018","journal-title":"Eur J Paediatr Neurol \u2013 Off J Eur Paediatr Neurol Soc"},{"key":"10.1016\/j.ejpn.2019.05.007_bib13","first-page":"23","article-title":"De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome","volume":"16","author":"Torres","year":"2018","journal-title":"Mol Genet Metabol Rep"},{"issue":"3","key":"10.1016\/j.ejpn.2019.05.007_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.celrep.2017.12.074","article-title":"Integrative analyses of de novo mutations provide deeper biological insights into autism spectrum disorder","volume":"22","author":"Takata","year":"2018","journal-title":"Cell Rep"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379819301758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379819301758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:37:04Z","timestamp":1761071824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379819301758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1090379819301758"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2019.05.007","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expanding spectrum of ATP1A3 related disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}